Form 4 holding
Chief Financial Officer
Indaptus Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 26,758
- Estimated value
- $54,318
- Report date
- 22 Dec 2025
- Price
- $2.03
- Ownership
- Direct
Nir Sassi
Insider Reports History
- Reporting-owner location
- ModIIn, Israel
- Latest reporting-owner signature
-
/s/ Nir Sassi
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Nir Sassi
Form 4 holding
Chief Financial Officer
Indaptus Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 10 Apr 2025
- Price
- $0.0710
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Nir Sassi
4
INDP
Indaptus Therapeutics, Inc.
- Report period
- 22 Dec 2025
- Transactions
- 1
- Transaction value
- +$54,319
- Accepted by SEC
- 29 Dec 2025, 16:01
- Role
- Chief Financial Officer
- Next action
- Open filing details
4
INDP
Indaptus Therapeutics, Inc.
- Report period
- 10 Apr 2025
- Transactions
- 7
- Transaction value
- -$500
- Accepted by SEC
- 11 Apr 2025, 16:15
- Role
- Chief Financial Officer
- Next action
- Open filing details
4
INDP
Indaptus Therapeutics, Inc.
- Report period
- 09 Oct 2024
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 10 Oct 2024, 16:05
- Role
- Chief Financial Officer
- Next action
- Open filing details
4
INDP
Indaptus Therapeutics, Inc.
- Report period
- 22 Jan 2024
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 23 Jan 2024, 16:15
- Role
- Chief Financial Officer
- Next action
- Open filing details
4
INDP
Indaptus Therapeutics, Inc.
- Report period
- 18 Jan 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 20 Jan 2023, 15:05
- Role
- Chief Financial Officer
- Next action
- Open filing details
4
INDP
Indaptus Therapeutics, Inc.
- Report period
- 25 Feb 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 28 Feb 2022, 15:30
- Role
- Chief Financial Officer
- Next action
- Open filing details
4
INDP
Indaptus Therapeutics, Inc.
- Report period
- 04 Aug 2021
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 06 Aug 2021, 17:00
- Role
- Chief Financial Officer
- Next action
- Open filing details
3
INDP
Intec Parent Inc.
- Report period
- 23 Jul 2021
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 02 Aug 2021, 16:45
- Role
- Chief Financial Officer
- Next action
- Open filing details